- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05415514
Feasibility Study of the Instrumented Evaluation of Eccentric Strengthening in Paresis Patients (RE PAR EX)
he aim of the "RE PAR EX" research is to evaluate the feasibility of the instrumented examination of the effects of eccentric muscle strengthening in paralytic patients. This project is part of the research axis of the movement analysis laboratory.
Following a stroke or spinal cord injury, patients develop a spastic paresis syndrome, which is characterized by the appearance of paresis, musculo-tendinous retractions and muscular hyperactivities.
If the traditional treatments proposed (stretching, motor work) show limits, the use of eccentric muscle strengthening in paresis patients has been developing for about ten years, with results superior to the usual treatments. The results of the studies evaluating it are focused on clinical evaluations and do not make it possible to identify the precise origin of the observed responses.
A pathophysiological understanding of the therapeutic effects of eccentric strengthening would be possible through instrumented examination of muscle structure and function, combining dynamometry, ultrasound, elastrography and electromyography (EMG). However, the feasibility of this quantified instrumental examination in paretic patients during a strengthening protocol has not been evaluated.
The feasibility of a quantified instrumented examination in this setting is the aim of this research, a necessary prerequisite for a larger interventional study to evaluate the biomechanical and neurophysiological effects of eccentric muscle strengthening in paretic patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Thomas Lecharte
- Phone Number: 02 44 76 89 89
- Email: Thomas.lecharte@chu-nantes.fr
Study Locations
-
-
-
Nantes, France, 44000
- Recruiting
- CHU de Nantes
-
Contact:
- Thomas Lecharte
- Phone Number: 0244768989
- Email: thomas.lecharte@chu-nantes.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient aged 18 to 80 years;
- Validation by the medical team of an eccentric strengthening protocol:
presence of a paresis of the studied muscle considered as functionally (triceps surae rated at 2 or more on the MRC scale), more or less associated with HAM and muscl retraction;
- Patient with a traumatic or ischemic spinal cord injury of grade Asia Impairment Scale (AIS) C or D (incomplete motor impairment) < 6 months or stroke < 6 months;
- Patient is competent to consent (Boston Diagnostic Aphasia Examination [BDAE] score greater than or equal to 2);
- Patient hospitalized in the neurological PRM service of the Nantes University Hospital.
Exclusion Criteria:
- History of functional surgery < 3 months ;
- Patient with osteoarticular lesions considered as a contraindication to to rehabilitation;
- Patient who is unlikely to adhere to the study program and/or not compliant compliant in the judgment of the investigator or refusing to participate in the study;
- Patients with a progressive pathology that contraindicates major muscular efforts (syrinx, cancer, etc.) (syrinx, cancer, cardiovascular instability...);
- Patients who are minors, protected adults, adults unable to express their consent or pregnant woman.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Instrumented assessment of muscle function
During the instrumented evaluations, the investigators will evaluate the possibility of measuring the passive and active function of the muscle using: - an isokinetic dynamometer, an ultrasound and elastography device, an electrical stimulation of the calf nerve
|
During the instrumented evaluations, we will evaluate the possibility of measuring the passive and active function of the muscle using: - an isokinetic dynamometer, an ultrasound and elastography device, an electrical stimulation of the calf nerve
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
proportion of usable data collected (ultrasound and elastographic images, EMG, force curves, etc.) compared to the expected usable data
Time Frame: 14 weeks
|
14 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To measure the duration of the examinations
Time Frame: 14 weeks
|
14 weeks
|
the average length of stay of included patients
Time Frame: 14 weeks
|
14 weeks
|
the patient's opinion through a self-questionnaire of satisfaction
Time Frame: 14 weeks
|
14 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thomas Lecharte, Nantes University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC22_0173
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Paralysis
-
Neurotrigger LtdRecruitingParalysis | Paralysis; Eye | Paralysis; BellIsrael
-
Assistance Publique - Hôpitaux de ParisCompletedUnilateral Diaphragmatic ParalysisFrance
-
University Hospital, RouenUniversity Hospital, CaenCompleted
-
Seoul National University HospitalCompleted
-
Lawson Health Research InstituteSuspended
-
University of MinnesotaCompleted
-
Ben-Gurion University of the NegevCompleted
-
Brigham and Women's HospitalCompletedPhrenic Nerve ParalysisUnited States
-
Shenzhen People's HospitalUnknownPhrenic Nerve ParalysisChina
-
Ajou University School of MedicineWithdrawnPhrenic Nerve ParalysisKorea, Republic of
Clinical Trials on Instrumented assessment of muscle function
-
RWTH Aachen UniversityNot yet recruitingCovid19 | Diaphragm InjuryGermany
-
RWTH Aachen UniversityRecruitingCovid19 | Diaphragm InjuryGermany
-
Rambam Health Care CampusCompletedSmoking Cessation | Muscle Weakness | Body Composition, BeneficialIsrael
-
HabibedurduCompletedIdiopathic Pulmonary Fibrosis | Interstitial Lung Disease | Sarcoidosis, Pulmonary | GeriatricTurkey
-
Herlev HospitalOdense University HospitalRecruitingChronic Kidney Diseases | Sarcopenia | OsteoporosisDenmark
-
Biruni UniversityAtlas UniversityCompletedChronic Obstructive Pulmonary DiseaseTurkey
-
Hospices Civils de LyonNot yet recruitingSpinal Muscular AtrophyFrance
-
Rigshospitalet, DenmarkMerck Sharp & Dohme LLC; Roche Pharma AG; Beckett Foundation; Onkologisk ForskningsfondUnknownUrinary Bladder NeoplasmDenmark
-
University of New MexicoNational Cancer Institute (NCI)Active, not recruiting
-
University Hospital, MontpellierCompleted